SCHEMBL2581369

SCHEMBL2581369

Cc1csc(C2CCC(C(=O)O)CC2)n1

nearest known ligand 0.44

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.43
RAB9A P51151 2/20 0.43
NPSR1 Q6W5P4 2/20 0.42
KDM4E B2RXH2 1/20 0.42
USP2 O75604 1/20 0.42
HPGD P15428 1/20 0.42
HSD17B10 Q99714 1/20 0.42
TP53 P04637 1/20 0.39
TRPV1 Q8NER1 7/20 0.39
OGA O60502 1/20 0.38
NPC1 O15118 1/20 0.38
GPR35 Q9HC97 1/20 0.38
DGAT1 O75907 1/20 0.37
SOAT1 P35610 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
AKR1C3 P42330 1/20 0.37
AKR1C1 Q04828 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2581366 1.00 ALDH1A1 (0.43) ALDH1A1RAB9ANPSR1KDM4EUSP2
SCHEMBL16104434 0.86 RAB9A (0.42) ALDH1A1RAB9ANPSR1KDM4ETP53
SCHEMBL6840373 0.84
Ammonia Solution, Strong SCHEMBL27924535 0.82 OGA (0.45) ALDH1A1RAB9ANPSR1HSD17B10TP53
SCHEMBL2588368 0.82 RAB9A (0.49) ALDH1A1RAB9ANPSR1TP53TRPV1
SCHEMBL2588367 0.82 RAB9A (0.49) ALDH1A1RAB9ANPSR1TP53TRPV1
SCHEMBL2589672 0.81 MAPT (0.42) ALDH1A1RAB9AKDM4EUSP2HPGD
SCHEMBL2589678 0.81 MAPT (0.42) ALDH1A1RAB9AKDM4EUSP2HPGD
SCHEMBL17541543 0.78 HSD11B1 (0.47) ALDH1A1RAB9AOGA
SCHEMBL21679349 0.78 SMN1; SMN2 (0.52) ALDH1A1RAB9ANPSR1KDM4EHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2569319-B1 HETEROARYL-CYCLOHEXYL-TETRAAZABENZO[E]AZULENES HOFFMANN LA ROCHE (CH) 2014-09-24 EP disclosed
US-8513238-B2 Heteroaryl-cyclohexyl-tetraazabenzo[E]azulenes HOFFMANN-LA ROCHE INC. (US) 2013-08-20 US disclosed
EP-2569319-A1 HETEROARYL-CYCLOHEXYL-TETRAAZABENZO[E]AZULENES F.HOFFMANN-LA ROCHE AG (CH) 2013-03-20 EP disclosed
WO-2011141396-A1 HETEROARYL-CYCLOHEXYL-TETRAAZABENZO[E]AZULENES F. HOFFMANN-LA ROCHE AG (CH) 2011-11-17 WO disclosed
US-20110275801-A1 HETEROARYL-CYCLOHEXYL-TETRAAZABENZO[E]AZULENES HOFFMANN-LA ROCHE, INC. 2011-11-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110275801-A1 HETEROARYL-CYCLOHEXYL-TETRAAZABENZO[E]AZULENES AVPR1A, AVPR1B, OXTR ALDH1A1 564/4885RAB9A 724/4885NPSR1 13/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.